Pancreatic Neoplasms: all 3,310 studies
Page 32 of 34. Open to participants first (910), then studies with results posted, then the rest; newest registration first within each.
- Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By SurgeryCompletedNCT00303758Phase 3
- Safety and Efficacy of the Therapeutic Vaccine GI-4000 in Combination With Gemcitabine Versus Placebo for the Treatment of Non-metastatic, Post-resection Pancreas CancerCompletedNCT00300950Phase 2
- Pancreatic Cancer Serum and DNA RepositoryCompletedNCT00296114
- Z-360 in Unresectable Advanced Pancreatic Cancer in Combination With Gemcitabine TreatmentCompletedNCT00288925Phase 1/2
- 3-AP and Radiation Therapy in Treating Patients With Stage III Pancreatic Cancer That Cannot Be Removed By SurgeryCompletedNCT00288093Phase 1
- Imatinib Mesylate and Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Pancreatic CancerTerminatedNCT00281996Phase 1
- Randomized Trial of EUS Neurolysis in Pancreas CancerCompletedNCT00279292Phase 3
- Gemcitabine and Oxaliplatin Followed By Radiation Therapy, Fluorouracil, and Oxaliplatin in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By SurgeryStatus unknownNCT00275119Phase 2
- The Efficacy and Safety of Gemcitabine in Combination With Docetaxel to Treat Pancreatic or Biliary CancerCompletedNCT00268840Phase 2
- Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Pancreatic CancerStatus unknownNCT00268411Phase 3
- Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract CancerCompletedNCT00266097Phase 1
- AZD0530 and Gemcitabine in Locally Advanced/Metastatic Pancreatic Cancer That Cannot Be Removed By SurgeryCompletedNCT00265876Phase 1/2
- GEMOX: Oxaliplatin in Pancreatic CancerCompletedNCT00261092Phase 2
- Combining Erlotinib Plus Bevacizumab and Gemcitabine Plus Capecitabine to Treat Advanced Pancreatic CancerCompletedNCT00260364Phase 1/2
- Three New Methods for Diagnosing Pancreas CancerStatus unknownNCT00259532Not applicable
- Vaccine Treatment for Surgically Resected Pancreatic CancerCompletedNCT00255827Phase 1/2
- Gemcitabine Hydrochloride With or Without Bevacizumab in Treating Patients Who Are Undergoing Surgery for Pancreatic CancerWithdrawnNCT00253526Phase 2
- Doxil Topotecan Doublet Cancer StudyCompletedNCT00252889Phase 1
- Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Non-Metastatic Pancreatic CancerCompletedNCT00251355Phase 1
- A Study of MLN8054 in Patients With Advanced Solid TumorsTerminatedNCT00249301Phase 1
- A Phase II Trial of CG 8020 and CG 2505 in Patients With Nonresectable or Metastatic Pancreatic CancerCompletedNCT00245362Phase 2
- Pilot Study Using Neoadj Chemo-Rad & EGFR-tyrosine Kinase Inhibitor for Potentially Resectable Pancreatic CancerCompletedNCT00243854Phase 1
- Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic CancerCompletedNCT00242190Phase 1/2
- Calcitriol and Docetaxel in Treating Patients With Metastatic or Locally Advanced Pancreatic CancerCompletedNCT00238199Phase 2
- IRESSA Combined With Radiotherapy & Gemcitabine as First-Line Treatment in Locally Advanced Pancreatic CancerCompletedNCT00234416Phase 1/2
- Cyberknife Radiosurgery for Locally Advanced Pancreatic CancerCompletedNCT00233415Phase 2
- Efficacy Study of Gemcitabine, Paclitaxel, and Irradiation in the Treatment of Pancreatic CancerWithdrawnNCT00226746Phase 2
- Ghrelin Levels in Pancreatic Cancer PatientsCompletedNCT00225745
- Cancer Detection in Pancreatic CystsCompletedNCT00222898
- Combination Chemotherapy for 1st Line Treatment of Advanced or Metastatic Pancreatic CancerCompletedNCT00222469Phase 2
- Safety Study of Combination Chemotherapy in Patients With Metastatic Solid Tumors or Adenocarcinoma of the PancreasCompletedNCT00220649Phase 1
- Phase I/II Study of Oral S-1 Plus Gemcitabine in Patients With Metastatic Pancreatic CancerSuspendedNCT00209677Phase 1/2
- Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic CancerCompletedNCT00202800Phase 2
- Gemcitabine With Curcumin for Pancreatic CancerCompletedNCT00192842Phase 2
- Irinotecan, Gemcitabine and Radiation Therapy for Pancreatic CancerCompletedNCT00192712Phase 2/3
- Gemcitabine, Oxaliplatin and Radiotherapy in Treating Patients With Completely Resected Pancreatic CancerCompletedNCT00191568Phase 2
- A Phase I/II Study of Lenalidomide in Combination With Gemcitabine in Patients With Untreated Advanced Carcinoma of the PancreasTerminatedNCT00179751Phase 1/2
- Hyperthermia With Chemotherapy for Locally Advanced or Metastatic Pancreas CancerStatus unknownNCT00178763Phase 2
- Celecoxib, Irinotecan and Concurrent Radiotherapy in Preoperative Pancreatic CancerTerminatedNCT00177853Phase 1
- Study of Gefitinib and Docetaxel as Salvage Therapy in Advanced Pancreatic CarcinomaCompletedNCT00177242Phase 2
- Gemcitabine, Cisplatin, and Celecoxib Treatment of Metastatic Pancreatic CancerCompletedNCT00176813Phase 2
- Capecitabine and Radiation Therapy in Advanced Pancreatic CancerTerminatedNCT00176735Not applicable
- Biliary Tissue Sampling Using a Cytology Brush or the GIUM CatheterStatus unknownNCT00160836Phase 1
- Genes as Predictors of Response to Gemcitabine, Docetaxel, and Capecitabine (GTX) in Metastatic or Unresectable Pancreatic Cancer.TerminatedNCT00159471Not applicable
- A Phase II Study of Combine Modality Therapy in Locally Advanced Pancreatic CancerStatus unknownNCT00149578Phase 2
- Docetaxel in Combination With Iressa in Previously Treated Patients With Pancreatic CancerCompletedNCT00137761Phase 2
- Acupuncture For Pancreatic Cancer PainCompletedNCT00136669Phase 3
- Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic CancerCompletedNCT00128622Phase 1
- Gemcitabine, Cisplatin, and Bevacizumab in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00126633Phase 2
- Tarceva and Capecitabine for Pancreatic CancerCompletedNCT00125021Phase 2
- Evaluation of Safety of Rexin-G Gene Transfer for Advanced Pancreatic CancerTerminatedNCT00121745Phase 1
- Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the PancreasTerminatedNCT00116389Phase 2
- Capecitabine, Bevacizumab, and Radiation Therapy Followed By Gemcitabine and Bevacizumab in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By SurgeryCompletedNCT00114179Phase 2
- Orathecin + Gemcitabine Versus Placebo + Gemcitabine in Chemonaive Non-Resectable Pancreatic CancerTerminatedNCT00113256Phase 2/3
- Radiation Therapy and Docetaxel With Either Fluorouracil or Cisplatin as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By SurgeryCompletedNCT00112697Phase 2
- Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00112658Phase 2/3
- Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00112528Phase 2
- Paclitaxel in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic CancerCompletedNCT00111904Phase 2
- Opioid Growth Factor in Treating Patients With Advanced Pancreatic Cancer That Cannot Be Removed By SurgeryCompletedNCT00109941Phase 2
- Study of Safety and Efficacy of Glufosfamide in Combination With Gemcitabine in CancerCompletedNCT00102752Phase 1/2
- ARQ 501 in Combination With Gemcitabine in Subjects With Pancreatic CancerCompletedNCT00102700Phase 2
- Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung CancerCompletedNCT00101348Phase 1/2
- Surgery for Pancreatic Tumors and Collection of Tumor Tissue for StudyTerminatedNCT00100321
- Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic CancerCompletedNCT00099294Phase 3
- Radiotherapy Combined With Oxaliplatin and Fluorouracil Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic CancerCompletedNCT00096070Phase 2
- Sorafenib and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerCompletedNCT00095966Phase 2
- Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerCompletedNCT00088894Phase 3
- PANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing RegimenStatus unknownNCT00088660Phase 3
- EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung CancerTerminatedNCT00087191Not applicable
- Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the PancreasCompletedNCT00085371Phase 2
- Cisplatin, Metronomic Low-Dose Interferon Alfa, Gemcitabine, and Fever-Range Whole-Body Hyperthermia in Treating Patients With Inoperable or Metastatic Pancreatic CancerStatus unknownNCT00082862Phase 2
- Aroplatin and Gemcitabine in Patients With Advanced Pancreatic Cancer Resistant to Standard TherapiesStatus unknownNCT00081549Phase 1/2
- Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the PancreasStatus unknownNCT00079365Not applicable
- 3-AP and Gemcitabine in Treating Patients With Recurrent, Unresectable, or Metastatic Pancreatic CancerCompletedNCT00078975Phase 2
- Tipifarnib and Radiation Therapy in Treating Patients With Unresectable Locally Advanced Pancreatic CancerCompletedNCT00077519Phase 1
- S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas CancerCompletedNCT00075686Phase 3
- CCI-779 in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerCompletedNCT00075647Phase 2
- Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic AdenocarcinomaStatus unknownNCT00075452Phase 3
- Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00068432Phase 2
- Immunotoxin Therapy in Treating Patients With Advanced Solid TumorsCompletedNCT00066651Phase 1
- Gemcitabine and Radiation Therapy Compared With Gemcitabine Alone in Treating Patients Who Have Undergone Surgery for Pancreatic CancerCompletedNCT00064207Phase 2/3
- 3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic CancerCompletedNCT00064051Phase 2
- Erlotinib, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic CancerCompletedNCT00063947Phase 1
- Alanosine in Treating Patients With CancerCompletedNCT00062283Phase 2
- A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Pancreatic Cancer Related CachexiaCompletedNCT00060502Phase 2
- Perifosine in Treating Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic CancerCompletedNCT00059982Phase 2
- Adjuvant Chemoradiotherapy and Interferon Alfa in Treating Patients With Resected Pancreatic CancerCompletedNCT00059826Phase 2
- Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic CancerCompletedNCT00058201Phase 3
- Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerCompletedNCT00058149Phase 3
- A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid MalignanciesStatus unknownNCT00057395Phase 1/2
- ABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic CancerCompletedNCT00056537Phase 1
- A Study With LY293111, Gemcitabine and Placebo in Patients With Pancreatic CancerCompletedNCT00055250Phase 2
- Perifosine in Treating Patients With Advanced Pancreatic CancerCompletedNCT00053924Phase 2
- Arsenic Trioxide in Treating Patients With Pancreatic Cancer That Has Not Responded to GemcitabineCompletedNCT00053222Phase 2
- Bortezomib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00052689Phase 2
- A Study of TNFerade™ Biologic With 5-FU and Radiation Therapy for First-Line Treatment of Unresectable Locally Advanced Pancreatic CancerCompletedNCT00051467Phase 3
- Gemcitabine Combined With Mistletoe in Treating Patients With Advanced Solid TumorsTerminatedNCT00049608Phase 1
- Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic CancerCompletedNCT00049348Phase 2
- Study of Combined RHUMAB VEGF and Capecitabine-based Chemoradiation for Patients With Locally Advanced Pancreatic CancerCompletedNCT00047710Phase 1
- Flavopiridol Plus Radiation Therapy Followed By Gemcitabine Hydrochloride in Treating Patients With Locally Advanced, Unresectable Pancreatic CancerCompletedNCT00047307Phase 1